Class 2 Medicines Recall: Aripiprazole 1mg/ml oral solution (EL (19)A/20)
Accord-UK Ltd is recalling the above batches due to the potential for small particles of Aripiprazole active material to be present which may affect the efficacy of the product. No relevant product complaints or adverse reaction reports have been received by the company from the UK market to date.
MDR Number
MDR 84-07/19
Company name
Accord-UK Ltd in Actavis Livery
Product description
| Batch number | Expiry date | Pack size | First distributed |
|---|---|---|---|
| 080618 | 06/2020 | 150ml | 08 Aug 2018 |
| 090618 | 06/2020 | 150ml | 03 Sept 2018 |
Brief description of the problem
Accord-UK Ltd is recalling the above batches due to the potential for small particles of Aripiprazole active material to be present which may affect the efficacy of the product. No relevant product complaints or adverse reaction reports have been received by the company from the UK market to date.
Advice for healthcare professionals and wholesalers
Stop supplying the batches listed above immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Company contact details for further information
For stock control enquiries please contact Accord-UK Ltd Customer Services Team on 0800 373573
For medical information enquiries please contact Accord-UK Ltd Medical Information Department on 01271 385257
Additional information
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. NHS Regional teams are asked to forward this to relevant clinics, general practitioners and community pharmacists.
Download the document